Protocol Status: PUBLISHED
Protocol:
Version: 2026.01
Effective Date:
Last Reviewed:
Medical Director Approval:
Clinical Note: This content reflects current GCEMS clinical guidelines as of the dates listed above. If content appears inconsistent with current policy, use the most recent approved guideline and notify leadership for correction.

Bradycardia

 

History:

 

  • Past medical history
  • Medications
    • Beta blockers
    • Clonidine
    • Calcium channel blockers
    • Digoxin
  • Pacemaker

 

Significant findings:

 

  • HR <60
  • Acute CHF
  • Seizures
  • Chest pain
  • Respiratory distress
  • Hypotension or shock secondary to bradycardia
  • Acute altered mental status
  • Syncope

 

Differential:

 

  • Acute MI
  • Hypoxia
  • Pacemaker failure
  • Hypothermia
  • Athletes
  • Head injury (elevated ICP)
  • Stroke
  • Spinal cord lesion
  • AV blocks (1st⁰, 2nd⁰, or 3rd⁰)
  • Overdose

 

Treatment

 

  • Oxygen
  • 12-Lead EKG
  • Initiate IV/IO

 

HR <60 with signs or symptoms of poor perfusion caused by the bradycardia?

 

    • Acute AMS
    • Syncope
    • Ongoing Chest Pain
    • Shortness of Breath
    • Hypotension
    • Acute CHF
    • Seizure
    • Other signs of shock

 

  • Yes

 

    • Atropine 1 mg mg IV/IO; may repeat every 3-5 minutes; max 3 mg

 

  • No

 

    • Continue to monitor and reassess

 

Improving?

 

  • Yes

 

    • Notify receiving facility or contact Medical Control

 

  • No

 

 

 

          • OR

 

 

    • Notify receiving facility or contact Medical Control

 

PEARLS:

 

  • If bradycardic patient is also a STEMI, follow the STEMI guidelines.
  • Transcutaneous Pacing: set rate for 70 beats per minute. Increase current (mA) until electrical and mechanical capture occure or pacing current reaches (200 mA)
  • Demand and Non-Demand Pacing
  • Conscious Sedation, Dose should be titrated to provide comfort without causing unconsciousness or respiratory failure. Be sure to monitor patient's breathing/ventilations, blood pressure and O2 saturation.
  • Pacing can be considered first for critical patients in the presence of 2nd⁰ or 3rd⁰ heart block.
  • Atropine will not work on a heart transplant patient. Transcutaneous pacing and/or Epinephrine drip is indicated.
  • Consider Glucagon (GlucaGen) 2 mg IV/IO, if patient is still bradycardic and on beta blockers
  • Consider Calcium Gluconate (Kalcinate) 5-20 mL IV/IO if patient is still bradycardic and on calcium channel blockers.
  • The use of Lidocaine (Xylocaine), Amiodarone (Cordarone) and calcium channel blockers in heart block can worsen bradycardia and lead to death.
  • In wide complex slow rhythm, consider hyperkalemia.